Boston Scientific Corporation Detailed Financials
Full historical quarterly statements
| Metric | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 |
|---|---|---|---|---|---|---|---|---|
| Total Revenue | 5.20B | 5.29B | 5.07B | 5.06B | 4.66B | 4.56B | 4.21B | 4.12B |
| Cost of Goods Sold | 1.59B | 1.35B | 1.52B | 1.64B | 1.71B | 1.89B | 1.56B | 1.53B |
| Gross Profit | 3.61B | 3.94B | 3.54B | 3.42B | 2.95B | 2.67B | 2.65B | 2.58B |
| R&D Expenses | 516.0M | 569.0M | 514.0M | 526.0M | 443.0M | 460.0M | 407.0M | 383.0M |
| Operating Expenses | 2.54B | 2.73B | 2.49B | 2.60B | 2.05B | 2.08B | 1.97B | 1.84B |
| Operating Income | 1.07B | 1.21B | 1.05B | 819.0M | 896.0M | 589.0M | 674.0M | 747.0M |
| Other Income / Gains | 90.0M | -506.0M | -111.0M | 122.0M | -91.0M | -4.0M | -6.0M | -327.0M |
| Net Income | 1.34B | 668.0M | 755.0M | 793.0M | 674.0M | 566.0M | 469.0M | 324.0M |
| EPS (Diluted) | 0.90 | 0.45 | 0.51 | 0.54 | 0.456 | 0.384 | 0.319 | 0.22 |
| Reported Currency | USD | USD | USD | USD | USD | USD | USD | USD |
| Gross Profit Ratio | 0.694 | 0.745 | 0.699 | 0.677 | 0.633 | 0.586 | 0.629 | 0.627 |
| General And Administrative Expenses | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Selling And Marketing Expenses | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Selling General And Administrative Expenses | 1.78B | 1.83B | 1.74B | 1.72B | 1.60B | 1.61B | 1.56B | 1.45B |
| Other Expenses | 244.0M | 328.0M | 237.0M | 363.0M | 14.0M | 10.0M | 5.0M | 9.0M |
| Cost And Expenses | 4.13B | 4.08B | 4.01B | 4.24B | 3.77B | 3.97B | 3.54B | 3.37B |
| Interest Income | 0 | 0 | 0 | 0 | 0 | 22.0M | 0 | 0 |
| Interest Expense | 90.0M | 90.0M | 87.0M | 90.0M | 87.0M | 139.0M | 83.0M | 81.0M |
| Depreciation And Amortization | 0 | 0 | 342.0M | 336.0M | 325.0M | 348.0M | 307.0M | 311.0M |
| Ebitda | 1.07B | 956.0M | 1.37B | 1.37B | 1.22B | 1.07B | 1.06B | 812.0M |
| Ebitdaratio | 0.206 | 0.181 | 0.27 | 0.27 | 0.261 | 0.235 | 0.251 | 0.197 |
| Operating Income Ratio | 0.206 | 0.228 | 0.207 | 0.162 | 0.192 | 0.129 | 0.16 | 0.181 |
| Income Before Tax | 1.16B | 700.0M | 939.0M | 941.0M | 805.0M | 585.0M | 668.0M | 420.0M |
| Income Before Tax Ratio | 0.223 | 0.132 | 0.185 | 0.186 | 0.173 | 0.128 | 0.159 | 0.102 |
| Income Tax Expense | -176.0M | 31.0M | 183.0M | 146.0M | 133.0M | 23.0M | 200.0M | 98.0M |
| Net Income Ratio | 0.257 | 0.126 | 0.149 | 0.157 | 0.145 | 0.124 | 0.111 | 0.079 |
| Epsdiluted | 0.90 | 0.45 | 0.50 | 0.53 | 0.451 | 0.38 | 0.315 | 0.218 |
| Weighted Average Shs Out | 1.48B | 1.48B | 1.48B | 1.48B | 1.48B | 1.47B | 1.47B | 1.47B |
| Weighted Average Shs Out Dil | 1.50B | 1.50B | 1.50B | 1.49B | 1.49B | 1.49B | 1.49B | 1.48B |